Reply - 24/12/11
Doi : 10.1016/j.jaci.2011.08.043
Antonino Romano, MD a, b 
, Maria J. Torres, MD, PhD c, Mariana Castells, MD, PhD d, Maria L. Sanz, MD, PhD e, Miguel Blanca, MD, PhD c
, Maria J. Torres, MD, PhD c, Mariana Castells, MD, PhD d, Maria L. Sanz, MD, PhD e, Miguel Blanca, MD, PhD c a Allergy Unit, Complesso Integrato Columbus, Rome, Italy
b IRCCS Oasi Maria S.S., Troina, Italy
c Allergy Service, Carlos Haya Hospital, Malaga, Spain
d Allergy Service, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass
e Allergy Service, Department of Allergy, University of Pamplona, Pamplona, Spain
Le texte complet de cet article est disponible en PDF.
| Disclosure of potential conflict of interest: M. Castells is on the Mastocytosis Society Medical Advisory Board, the Merck Consultant Adverse Drug Reactions Safety Committee, the Schering-Plough Adverse Drug Reactions Safety Committee, and the Abbott Consultant Adverse Drug Reactions Safety Committee. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2011
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 129 - N° 1
P. 265-266 - janvier 2012 Retour au numéro
Article précédent
- Drug hypersensitivity reactions: Inconsistency in the use of the classification of immediate and nonimmediate reactions
- Andreas J. Bircher, Kathrin Scherer Hofmeier
- Vascular endothelial–cadherin: A possible link between endocytosis and ectodomain shedding
- Ru-Yuan Zhang, Lei Li, Jun Wu, Yao-Qing Tang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?